Recent Study: Global Bone Marrow Transplant Market 2017-2021

Fast Market Research announces the availability of the new TechNavio report, "Global Bone Marrow Transplant Market 2017-2021", on their comprehensive research portal

Logo

Boston, MA -- (SBWire) -- 07/17/2017 --Bone marrow transplant is the medical procedure that is performed to replace the damaged or destroyed bone marrow due to infections, disease, or adverse effect of treatment. A normal bone marrow transplant includes transplantation of blood stem cell that travels to the bone marrow to produce new blood cell and thus improves growth of new marrow. When the bone marrow is damaged due to disease, allogeneic transplant is used whereas autologous transplant is used when bone marrow is intact at the start of disease but it gets damaged due to therapy.

Technavio's analysts forecast the global bone marrow transplant market to grow at a CAGR of 5.39% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global bone marrow transplant market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

Get More Details on this Report and a Full Table of Contents at Global Bone Marrow Transplant Market 2017-2021

The market is divided into the following segments based on geography:

-Americas
-APAC
-EMEA

Technavio's report, Global Bone Marrow Transplant Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

-AllCells
-Lonza
-Merck
-Sanofi

Other prominent vendors

-Athersys
-Beike Biotechnology
-BioTime
-bluebird bio
-Caladrius
-Cellular Biomedicine Group
-Cellular Dynamics International (a subsidiary of Fujifilm)
-Cesca Therapeutics
-CHA Biotech
-Chugai Pharmaceutical
-CORESTEM
-Gamida Cell
-Global Stem Cells Group
-Hemostemix
-Histocell
-Mesoblast
-TiGenix
-Translational Biosciences (a subsidiary of Medistem Panama)

Market driver

-Technological advancement
-For a full, detailed list, view our report

Market challenge

-Scarcity of donors and its genetical acceptance
-For a full, detailed list, view our report

Market trend

-Growing number of registry
-For a full, detailed list, view our report

Key questions answered in this report

-What will the market size be in 2021 and what will the growth rate be?
-What are the key market trends?
-What is driving this market?
-What are the challenges to market growth?
-Who are the key vendors in this market space?
-What are the market opportunities and threats faced by the key vendors?
-What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Companies Mentioned in this Report: AllCells, Lonza, Merck, Sanofi, Athersys, Beike Biotechnology, BioTime, bluebird bio, Caladrius, Cellular Biomedicine Group, Cellular Dynamics International, Cesca Therapeutics, CHA Biotech, Chugai Pharmaceutical, CORESTEM, Gamida Cell, Global Stem Cells Group, Hemostemix, Histocell, Mesoblast, TiGenix, Translational Biosciences

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Healthcare research reports at Fast Market Research

You may also be interested in these related reports:
-Bone Marrow Transplant Rejection Global Clinical Trials Review, H1, 2017
-Bone Marrow Transplant Rejection Global Clinical Trials Review, H2, 2016
-Bone Marrow Transplant Rejection - Pipeline Review, H2 2016
-Bronchitis - Pipeline Review, H1 2017
-Global Serological Transplant Diagnostics Market 2017-2021

Media Relations Contact

Bill Thompson
Director of Marketing
Fast Market Research, Inc.
800-844-8156
http://www.fastmr.com

View this press release online at: http://rwire.com/833297